Browsing by Author Llovet i Bayer, Josep Maria
Showing results 1 to 20 of 45
next >
| Issue Date | Title | Author(s) |
|---|---|---|
| 22-Jun-2019 | An Immune Gene Expression Signature Associated With Development of Human Hepatocellular Carcinoma Identifies Mice That Respond to Chemopreventive Agents | Moeini, Agrin; Torrecilla, Sara; Tovar, Victoria; Montironi, Carla; Andreu Oller, Carmen; Peix, Judit; Higuera, Mónica; Pfister, Dominik; Ramadori, Pierluigi; Pinyol, Roser; Solé, Manel; Heikenwälder, Mathias; Friedman, Scott L.; Sia, Daniela; Llovet i Bayer, Josep Maria |
| 1994 | Bacterial translocation in cirrhotic rats. Its role in the development of spontaneous bacterial peritonitis | Llovet i Bayer, Josep Maria; Bartolí, R.; Planas Vilà, Ramon; Cabré i Gelada, Eduard; Jiménez, M.; Urban, A.; Ojanguren Sabán, Isabel; Arnal, J.; Gassull, Miquel Àngel |
| 12-Jan-2018 | Beta-catenin cleavage enhances transcriptional activation | Goretsky, Tatiana; Bradford, Emily M.; Ye, Qing; Lamping, Olivia F.; Vanagunas, Tomas; Moyer, Mary Pat; Keller, Patrick C.; Sinh, Preetika; Llovet i Bayer, Josep Maria; Gao, Tianyan; She, Qing-Bai; Li, Linheng; Barrett, Terrence A. |
| 1-May-2019 | Biomarkers Associated With Response to Regorafenib in Patients With Hepatocellular Carcinoma | Teufel, Michael; Seidel, Henrik; Koechert, Karl; Meinhardt, Gerold; Finn, Richard S.; Llovet i Bayer, Josep Maria; Bruix, Jordi |
| 9-Jan-2018 | Characterization of novel actionable molecular subgroups in Hepatocellular Carcinoma: Immune class and IGF2-driven tumors | Martínez Quetglas, Iris |
| 15-Jan-2020 | CNApp, a tool for the quantification of copy number alterations and integrative analysis revealing clinical implications. | Franch Expósito, Sebastià; Bassaganyas, Laia; Vila Casadesús, Maria; Hernández Illán, Eva; Esteban Fabró, Roger; Díaz Gay, Marcos; Lozano Salvatella, Juan José; Castells Garangou, Antoni; Llovet i Bayer, Josep Maria; Castellví Bel, Sergi; Camps, Jordi |
| 2002 | Cost-effectiveness of adjuvant therapy for hepatocellular carcinoma during the waiting list for liver transplantation. | Llovet i Bayer, Josep Maria; Mas, X.; Aponte, John J.; Fuster Obregón, Josep; Navasa, Miquel; Christensen, E.; Rodés, J.; Bruix Tudó, Jordi |
| Jun-2015 | DNA methylation-based prognosis and epidrivers in hepatocellular carcinoma | Villanueva, Augusto; Portela, Anna; Sayols, Sergi; Battiston, Carlo; Hoshida, Yujin; Méndez González, Jesús; Imbeaud, Sandrine; Letouzé, Eric; Hernández Gea, Virginia; Cornella, Helena; Pinyol, Roser; Solé Arqués, Manuel; Fuster Obregón, Josep; Zucman-Rossi, Jessica; Mazzaferro, Vincenzo; Esteller, Manel; Llovet i Bayer, Josep Maria; HEPTROMIC Consortium |
| 13-Nov-2020 | Effect of ramucirumab on ALBI grade in patients with advanced HCC: Results from REACH and REACH-2 | Kudo, Masatoshi; Galle, Peter R.; Brandi, Giovanni; Kang, Yoon Koo; Yen, Chia Jui; Finn, Richard S.; Llovet i Bayer, Josep Maria; Assenat, Eric; Merle, Philippe; Chan, Stephen L.; Palmer, Daniel H.; Ikeda, Masafumi; Yamashita, Tatsuya; Vogel, Arndt; Huang, Yi Hsiang; Abada, Paolo; Yoshikawa, Reigetsu; Shinozaki, Kenta; Wang, Chunxiao; Widau, Ryan C.; Zhu, Andrew X. |
| 1-Aug-2020 | Epigenetic footprint enables molecular risk stratification of hepatoblastoma with clinical implications | Carrillo Reixach, Juan; Torrens, Laura; Simon Coma, Marina; Royo, Laura; Domingo Sàbat, Montserrat; Abril Fornaguera, Jordi; Akers, Nicholas; Sala, Margarita; Ragull, Sonia; Arnal, Magdalena; Villalmanzo, Núria; Cairo, Stefano; Villanueva Garatachea, Alberto; Kappler, Roland; Garrido, Marta; Guerra, Laura; Sabado, Constantino; Guillén, Gabriela; Mallo, Mar; Piñeyro, David; Vázquez Vitali, María; Kuchuk, Olga; Mateos, María Elena; Ramírez, Gema; López Santamaría, Manuel; Mozo, Yasmina; Soriano, Aroa; Grotzer, Michael; Branchereau, Sophie; García de Andoin, Nagore; López Ibor, Blanca; López Almaraz, Ricardo; Salinas, José Antonio; Torres, Bárbara; Hernández, Francisco; Uriz, José Javier; Fabre, Monique; Blanco, Julià; Paris, Claudia; Bajciová, Viera; Laureys, Geneviève; Masnou, Helena; Clos, Ariadna; Belendez, Cristina; Guettier, Catherine; Sumoy, Lauro; Planas, Ramón; Jordà Ramos, Mireia; Nonell, Lara; Czauderna, Piotr; Morland, Bruce; Sia, Daniela; Losic, Bojan; Buendia, Marie Annick; Sarrias Fornés, Maria Rosa; Llovet i Bayer, Josep Maria; Armengol, Carolina |
| 14-Apr-2016 | Hepatocellular carcinoma | Llovet i Bayer, Josep Maria; Zucman-Rossi, Jessica; Pikarsky, Eli; Sangro, Bruno; Schwartz, Myron; Sherman, Morris; Gores, Gregory |
| 2001 | Hepatocellular carcinoma: is surveillance cost effective? | Bruix Tudó, Jordi; Llovet i Bayer, Josep Maria |
| 1-Sep-2017 | Identification of an immune-specific class of Hepatocellular Carcinoma, based on molecular features | Sia, Daniela; Jiao, Yang; Martínez Quetglas, Iris; Kuchuk, Olga; Villacorta Martin, Carlos; de Moura, Manuel Castro; Putra, Juan; Campreciós Figueras, Genís; Bassaganyas, Laia; Akers, Nicholas; Losic, Bojan; Waxman, Samuel; Thung, Swan N.; Mazzaferro, Vincenzo; Esteller, Manel; Friedman, Scott L.; Schwartz, Myron; Villanueva, Augusto; Llovet i Bayer, Josep Maria |
| 1-Dec-2016 | IGF2 is up-regulated by epigenetic mechanisms in Hepatocellular Carcinoma and is an actionable oncogene product in experimental models | Martínez Quetglas, Iris; Pinyol, Roser; Dauch, Daniel; Torrecilla, Sara; Tovar, Victoria; Moeini, Agrin; Alsinet, Clara; Portela, Anna; Rodríguez-Carunchio, Leonardo; Sole, Manel; Lujambio, Amaia; Villanueva, Augusto; Thung, Swan N.; Esteller, Manel; Zender, Lars; Llovet i Bayer, Josep Maria |
| 7-Jan-2019 | Immune Exclusion-Wnt/CTNNB1 Class Predicts Resistance to Immunotherapies in HCC | Pinyol, Roser; Sia, Daniela; Llovet i Bayer, Josep Maria |
| Nov-2021 | Immunomodulatory effects of lenvatinib plus anti-PD1 in mice and rationale for patient enrichment in hepatocellular carcinoma. | Torrens, Laura; Montironi, Carla; Puigvehí, Marc; Mesropian, Agavni; Leslie, Jack; Haber, Philipp K.; Maeda, Miho; Balaseviciute, Ugne; Willoughby, Catherine E.; Abril Fornaguera, Jordi; Piqué Gili, Marta; Torres Martín, Miguel; Peix, Judit; Geh, Daniel; Ramon Gil, Erik; Saberi, Behnam; Friedman, Scott L.; Mann, Derek A.; Sia, Daniela; Llovet i Bayer, Josep Maria |
| 15-Jan-2020 | Intratumoral heterogeneity and clonal evolution in liver cancer | Losic, Bojan; Craig, Amanda J.; Villacorta-Martin, Carlos; Martins-Filho, Sebastiao N.; Akers, Nicholas; Chen, Xintong; Ahsen, Mehmet Eren; von Felden, Johann; Labgaa, Ismail; Avola, Delia D'; Allette, Kimaada; Lira, Sergio A.; Furtado, Glaucia C.; Garcia-Lezana, Teresa; Restrepo, Paula; Stueck, Ashley; Ward, Stephen C.; Fiel, Maria I.; Hiotis, Spiros P.; Gunasekaran, Ganesh; Sia, Daniela; Schadt, Eric E.; Sebra, Robert; Schwartz, Myron; Llovet i Bayer, Josep Maria; Thung, Swan N.; Stolovitzky, Gustavo; Villanueva, Augusto |
| Mar-2016 | Liver Cancer Cell of Origin, Molecular Class, and Effects on Patient Prognosis | Sia, Daniela; Villanueva, Augusto; Friedman, Scott L.; Llovet i Bayer, Josep Maria |
| 14-Jun-2018 | Liver Cancer Disparities in New York City: A neighborhood wiew of risk and harm reduction factors | Kamath, Geetanjali R.; Taioli, Emanuela; Egorva, Natalia N.; Llovet i Bayer, Josep Maria; Perumalswami, Ponni V.; Weiss, Jeffrey J.; Schwartz, Myron; Ewala, Stanley; Bickell, Nina A. |
| 1996 | Low dose alpha interferon therapy can be effective in chronic active hepatitis C. Results of a multicentre, randomised trial | Forns, Xavier; Ampurdanés, Sergi; Titó Espinagosa, Llúcia; Planas Vilà, Ramon; Viver i Pi-Suñer, Josep M.; Acero i Fernández, Doroteo; Torres Salinas, Miguel; Mas, P.; Morillas Cunill, Rosa María; Forné Bardera, Montserrat; Espinós, J.; Llovet i Bayer, Josep Maria; Costa i Camps, Josep; Olmedo Casas, Eva; López Labrador, Francesc Xavier; Jiménez de Anta Losada, María Teresa; Rodés, J.; Sánchez Tapias, José M. (José María) |